(Reuters) -Activist investor Politan Capital Management has nominated candidates to Azenta's board and is working with the biotechnology company to address certain issues, a company filing disclosed on Wednesday.
The nominations include Quentin Koffey, who runs the hedge fund, and comes months after Politan raised its stake in the company to 7.5%.
The filing also showed that the two sides have signed a non-disclosure agreement and that Politan was currently in talks with Azenta's board over its business, strategies and corporate governance.
Politan has successfully pushed for changes at managed care company Centene and medical devices maker Masimo.
Centene settled to add five new directors and the CEO agreed to retire after Politan's push.
At Masimo, where Politan's Koffey won a proxy contest earlier this year, he secured two board seats, including one for himself.
Azenta did not immediately respond to a Reuters request for comment.
(Reporting by Svea Herbst-Bayliss and Pratik Jain; Editing by Anil D'Silva)